Evidence map›Paper›PMID 40109218›Full record

ArticleCancer biomarkers : section A of Disease markers2025

A simplified MyProstateScore2.0 for high-grade prostate cancer.

Tiffany M Tang, Yuping Zhang, Ana M Kenney, Cassie Xie, Lanbo Xiao, Javed Siddiqui, Sudhir Srivastava, Martin G Sanda, John T Wei, Ziding Feng and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer biomarkers : section A of Disease markers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Tiffany M TangDepartment of Statistics, University of Michigan, Ann Arbor, MI, USA.ORCID 0000-0002-8079-6867
Yuping ZhangDepartment of Pathology, University of Michigan, Ann Arbor, MI, USA.
Ana M KenneyDepartment of Statistics, University of California, Irvine, Irvine, CA, USA.
Cassie XieDepartment of Biostatistics, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Lanbo XiaoDepartment of Pathology, University of Michigan, Ann Arbor, MI, USA.
Javed SiddiquiDepartment of Pathology, University of Michigan, Ann Arbor, MI, USA.
Sudhir SrivastavaDivision of Cancer Prevention, National Institutes of Health, Bethesda, MD, USA.
Martin G SandaDepartment of Urology, Emory University, Atlanta, GA, USA.
John T WeiDepartment of Urology, University of Michigan, Ann Arbor, MI, USA.
Ziding FengDepartment of Biostatistics, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Jeffrey J TosoianDepartment of Urology, Vanderbilt University Medical Center, Nashville, TN, USA.
Yingye ZhengDepartment of Biostatistics, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Arul M ChinnaiyanDepartment of Pathology, University of Michigan, Ann Arbor, MI, USA.
Bin YuDepartments of Statistics and Electrical Engineering and Computer Science, University of California, Berkeley, CA, USA.
EDRN-PCA3 Study Group

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
The Early Detection Research Network: Data Management and Coordinating CenterU24CA086368 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI RUTH D ETZIONI, Ziding Feng · 2010 to 2026
$75.7M
Tissue/InformaticsP50CA186786 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Ganesh S Palapattu · 2014 to 2026
$27.6M
EDRN--DATA MANAGEMENT AND COORDINATING CENTERU01CA086368 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI FENG, ZIDING · 2000 to 2010
$16.9M
Prostate Cancer Biomarker and Imaging Validation Alliance: Emory University, University of Alabama Birmingham, and University of Texas SouthwesternU01CA113913 · NCI · EMORY UNIVERSITY · PI Martin G. Sanda · 2005 to 2026
$16.4M
Clinical and Analytical Validation of Cancer BiomarkersU24CA115102 · NCI · JOHNS HOPKINS UNIVERSITY · PI CHAN, DANIEL WANYUI · 2005 to 2021
$7.4M
Exploring Precision Oncology: From Gene Fusions to lncRNAsR35CA231996 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHINNAIYAN, ARUL M · 2018 to 2024
$6.4M
Michigan-VUMC Biomarker Characterization CenterU2CCA271854 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Jeffrey John Tosoian · 2022 to 2026
$5.4M
Howard Hughes Medical InstituteNCI NIH HHS P30 CA015704NCI NIH HHS P50 CA186786NCI NIH HHS R35 CA231996NCI NIH HHS U01 CA086368NCI NIH HHS U01 CA113913NCI NIH HHS U24 CA086368NCI NIH HHS U24 CA115102NCI NIH HHS U2C CA271854
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biomarkers, TumorProstatic NeoplasmsHumansMaleNeoplasm GradingBiomarkers, Tumormachine learningPCS for veridical data scienceprostate cancertrustworthy AIurine biomarker

Identifiers

PMID40109218
PMCPMC12135703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.